Saturday - November 23, 2024
Avista Healthcare Partners Invests in Organogenesis Holdings' Series A Convertible Preferred Stock
November 14, 2024
BOSTON, Massachusetts, Nov. 14 -- Ropes and Gray, a law firm, issued the following news:

Ropes & Gray represented Avista Healthcare Partners in the purchase of $130 million of Series A Convertible Preferred Stock from Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.

The transact . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products